PO.TB10.11 · 肿瘤生物学
癌细胞驱动的 HIF-1alpha 激活增强肺肿瘤微环境中癌症相关成纤维细胞的运动能力
Cancer cell-driven HIF-1alpha activation enhances the motility of cancer-associated fibroblasts in the lung tumor microenvironment
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
癌症相关成纤维细胞(CAFs)表现出显著的表型异质性,这由肿瘤微环境内的动态相互作用所驱动。为研究运动性驱动的 CAF 异质性,我们利用 3D 培养系统和光转换荧光蛋白 Dendra2,分离出“运动型”和“静止型”CAF 亚群。转录组分析揭示,运动型 CAFs 上调缺氧和糖酵解相关基因,而这些基因是 HIF-1alpha 的下游靶点。与这些发现一致,HIF-1alpha 激活增强了 CAF 运动能力,而敲低其下游靶点 ALDOA 和 LDHA 则显著降低了 CAF 运动能力。值得注意的是,间充质样肺癌细胞通过分泌因子同时增强了 CAFs 中 HIF-1alpha 活性和运动能力。利用质谱,我们鉴定出铜蓝蛋白(CP)是这些肺癌细胞分泌的关键蛋白,其转录受 EMT 诱导转录因子 ZEB1 调控。在功能上,敲低 CP 消除了肺癌细胞在体外促进 CAF 运动能力以及在体内转移的能力。总之,这些发现揭示了一种新机制,其中肺癌细胞分泌的 CP 促进 CAFs 中的 HIF-1alpha 信号,从而驱动其运动能力并促进转移。
查看英文原文 English abstract
Cancer-associated fibroblasts (CAFs) display significant phenotypic heterogeneity driven by dynamic interactions within the tumor microenvironment. To investigate motility-driven CAF heterogeneity, we utilized a 3D culture system and the photoconvertible fluorescent protein Dendra2, to isolate ‘motile' and ‘static' CAF subpopulations. Transcriptomic analyses revealed that motile CAFs upregulated hypoxia- and glycolysis-related genes, which are downstream targets of HIF-1alpha. In line with these findings, HIF-1alpha activation enhanced CAF motility, while the knockdown of its downstream targets, ALDOA and LDHA, significantly reduced CAF motility. Notably, mesenchymal-like lung cancer cells enhanced both HIF-1alpha activity and motility in CAFs through secretory factors. Using mass spectrometry, we identified ceruloplasmin (CP) as a key secretory protein from these lung cancer cells, whose transcription was regulated by the EMT-inducing transcription factor ZEB1. Functionally, CP knockdown abolished the ability of lung cancer cells to promote CAF motility in vitro and to metastasize in vivo. Collectively, these findings demonstrate a novel mechanism where lung cancer cell-secreted CP facilitates HIF-1alpha signaling in CAFs, thereby driving their motility and promoting metastasis.
利益披露 Disclosure
J. Park, None..
S. Lee, None..
J. M. Kurie, None..
Y. Ahn, None.